Skip to content

Discontinued — last reported Q1 '22

Net margin at other companies

Biogen logo
BiogenBIIB
14.3%-0.8pp
PTC Therapeutics logo
PTC TherapeuticsPTCT
42.3%+27.4pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
37.1%+0.2pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-125.9%-54.5pp
Arrowhead Research logo
Arrowhead ResearchARWR
-48.4%+240pp
Cytokinetics logo
CytokineticsCYTK
-784%-337pp

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Operating margin-231.8%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Calculated from Scholar Rock’s reported figures.

Based on trailing twelve months.

The official record: Scholar Rock’s 10-Q, filed May 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's net margin?
Scholar Rock (SRRK) reported net margin of -236.9% in Q1 2022.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.